MedMira Capex To Revenue from 2010 to 2024
| MIR Stock | CAD 0.08 0.00 0.00% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter 1.79978816 | Current Value 1.89 | Quarterly Volatility 1.39511136 |
Check MedMira financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MedMira's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.5 K, Selling General Administrative of 1.2 M or Selling And Marketing Expenses of 216.8 K, as well as many indicators such as Price To Sales Ratio of 175, Days Sales Outstanding of 1.2 K or Invested Capital of 0.0. MedMira financial statements analysis is a perfect complement when working with MedMira Valuation or Volatility modules.
MedMira | Capex To Revenue |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.